National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
May 29, 2012 • Volume 9 / Number 11

NEWS

Medical illustration of a sigmoidoscope in the colon. (Illustration by Terese Winslow for NCI)Sigmoidoscopy Proves to Be Effective Screening Tool for Colorectal Cancer

In a large randomized trial in healthy men and women aged 55 to 74, sigmoidoscopy substantially reduced the incidence of and mortality from colorectal cancer. Newly diagnosed cases of the disease fell by 21 percent and colorectal cancer deaths fell by 26 percent after a median of 12 years of follow-up. 

The findings, from the NCI-funded Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial appeared online May 21 in the New England Journal of Medicine. Read more > >

A MESSAGE TO READERS

Meet NCI Experts at ASCO 2012

NCI at ASCO banner NCI staff will participate in the upcoming American Society of Clinical Oncology's (ASCO) 48th Annual Meeting on June 1–5 at McCormick Place in Chicago, IL.
 
Attendees can learn about NCI's programs and resources by visiting booth #2047 in the exhibit hall during the meeting. Learn more about NCI-sponsored sessions and activities online, and look for additional highlights from the meeting in the June 12 issue of the NCI Cancer Bulletin.

IN DEPTH

UPDATES

  • Notes

    • In Memoriam: Cedric Long, Assistant Director of NCI's Division of Extramural Activities
    • NCI's Advanced Technology Research Facility Opens
    • NCI and China Cancer Institute Discuss Research Issues and Medical Journalism
    • Paula Jacobs Appointed Associate Director in NCI's Division of Cancer Treatment and Diagnosis
    • Proposals Sought for Use of PLCO Data and Biospecimens
    • Cyber-Seminar Will Examine Cancer Control at the State and Local Level


Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.

NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.

Next Section >